UPDATE | August 31, 2022

Large-Scale Continuous Biomanufacturing: Utilizing N-1 Technology for Higher Productivity and Quality

  • MAIL

LARGE-SCALE CONTINUOUS BIOMANUFACTURING UTILIZING N-1 TECHNOLOGY FOR HIGHER PRODUCTIVITY AND QUALITY 

 

To ensure a faster and more efficient process platform, Samsung Biologics has innovated the use of N-1 perfusion for commercialization-scale production, overcoming numerous challenges to ensure its utility in meeting the unique needs of each client. In this whitepaper, learn how we utilize large-scale continuous manufacturing to respond to increased demand, while maintaining the highest quality 

LARGE-SCALE CONTINUOUS BIOMANUFACTURING UTILIZING N-1 TECHNOLOGY FOR HIGHER PRODUCTIVITY AND QUALITY 

 

To ensure a faster and more efficient process platform, Samsung Biologics has innovated the use of N-1 perfusion for commercialization-scale production, overcoming numerous challenges to ensure its utility in meeting the unique needs of each client. In this whitepaper, learn how we utilize large-scale continuous manufacturing to respond to increased demand, while maintaining the highest quality

  • CDO
  • CGMP
  • ADC
  • Bio Campus
  • IR
  • CMO

Share article

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required